{
    "2019-11-20": [
        [
            {
                "time": "2019-05-10",
                "original_text": "Stocks remain under pressure after Trump threatens to raise tariffs if China trade talks languish",
                "features": {
                    "keywords": [
                        "tariffs",
                        "China trade talks",
                        "pressure"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "global trade",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "Stocks open lower as Trump threatens to raise tariffs if China trade talks languish",
                "features": {
                    "keywords": [
                        "open lower",
                        "tariffs",
                        "China trade talks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "global trade",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-15",
                "original_text": "Alkermes Submits NDA to FDA for Schizophrenia & Bipolar I Drug",
                "features": {
                    "keywords": [
                        "NDA",
                        "FDA",
                        "Schizophrenia",
                        "Bipolar I Drug"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "Eli Lilly to create 100 jobs in Indianapolis as it adds capacity to its technology center campus",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "jobs",
                        "Indianapolis",
                        "technology center"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-28",
                "original_text": "Lilly announces $400 million capital investment in manufacturing facilities in Indianapolis",
                "features": {
                    "keywords": [
                        "Lilly",
                        "capital investment",
                        "manufacturing",
                        "Indianapolis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "manufacturing"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}